Case Studies
 NatImmune
- Tired investors desiring a partnership of the lead protein replacement technology before further supporting the company
- Sage engaged Enzon as well as three other parties
- Closed a deal with $10 mil. in upfront fees and potential milestones of over $100 mil.
- Double digit royalties dependent on sales
- Investors re-invigorated.
- Company subsequently made an acquisition for new pipeline
|
Return to all case studies
|